Poor earnings, plus sagging crude oil, and an extraordinary loss in a patent case in the biotech sector, weighed on equities prices today.
Poor earnings, plus sagging crude oil, and an extraordinary loss in a patent case in the biotech sector, weighed on equities prices today.